Pathogen inactivation of RBCs: PEN110 reproductive toxicology studies

Transfusion

Volumn 43, Issue 10, 2003, Pages 1386-1393

  Chapman, John R ^a   Moore, Kristen ^b   Butterworth, Byron E ^b  

^a VI Technologies Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZIRIDINE DERIVATIVE; INACTINE; PEN 110; UNCLASSIFIED DRUG; POLYAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CORPUS LUTEUM; DEVICE; DOSE RESPONSE; EMBRYO; EMBRYO DEVELOPMENT; ERYTHROCYTE; ESTRUS CYCLE; FEMALE; FERTILITY; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; LEUKOCYTE; MALE; MAXIMUM TOLERATED DOSE; MICROBIAL CONTAMINATION; NIDATION; NONHUMAN; PREGNANCY RATE; PURIFICATION; RABBIT; RAT; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; URINARY EXCRETION; ANIMAL; BODY WEIGHT; DRUG EFFECT; EATING; ERYTHROCYTE TRANSFUSION; MICROBIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; EATING; EMBRYONIC AND FETAL DEVELOPMENT; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; FERTILITY; MALE; POLYAMINES; PREGNANCY; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0142135467     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00497.x     Document Type: Article

References (17)

1. Chapman J. Progress in improving the pathogen safety of red cell concentrates. Vox Sang 2000;78:203-4.
2. AuBuchon JP, Pickard CA, Herschel LH, et al. Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study. Transfusion 2002;42:146-52.
3. Snyder E, Mintz P, Burks S, et al, Pathogen inactivated red blood cells using INACTINE™ technology demonstrate 24 hour post transfusion recovery equal to untreated red cells after 42 days of storage. Blood 2001;98:709a,
4. Bahnemann HG. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 1990;8:299-303.
5. Budowsky EI, Zalesskaya MA, Nepomnyashchaya NM, et al. Principles of selective inactivation of the viral genome: dependence of the rate of viral RNA modification on the number of protonizable groups in ethylenimine oligomers. Vaccine Res 1996;5:29-39.
6. Lazo A, Tassello J, Jayarama J, et al. Broad-spectrum virus reduction in red cell concentrates using INACTINE™ PEN110 chemistry. Vox Sang 2002;83:313-23.
7. Ohagen A, Gibaja V, Aytay S, et al. Inactivation of HIV in blood. Transfusion 2002;42:1308-17.
8. Zavizion B, Serebryanik D, Serebryanik I, Chapman J, Purmal A. Prevention of Yersinia enterocolitica, Pseudomonas fluorescens, and Pseudomonas putida outgrowth in deliberately inoculated blood by a novel pathogen reduction process. Transfusion 2003;43:135-42.
9. Zavizion B, Jorge MM, Pereira MA, et al. The INACTINE™ PEN110 chemistry eradicates the parasites that cause Chagas' disease, malaria, and babesiosis. Vox Sang 2002; 83(Suppl 2):118-9.
10. Fast LD, DiLeone G, Edson CM, Purmal A. Inhibition of murine GVHD by PEN110 treatment. Transfusion 2002; 42:1326-32.
11. Fast LD, DiLeone G, Edson CM, Purmal A. PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to γ-irradiation. Transfusion 2002;42:1318-25.
12. Mirsalis JC, Tyson CK, Butterworth BE. Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay. Environ Mutagen 1982;4:553-62.
13. Ashby J, Tennant RW. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat Res 1991; 257:229-306.
14. Chapman J, Butterworth BE. Genetic toxicology profile of Inactine PEN110. Toxicologist 2000;66:73.
15. Halamka J, Gray JW, Gledhill BL, et al. Estimation of the frequency of malformed sperm by slit scan flow cytometry. Cytometry 1984;5:333-8.
16. Ashby J, Lefevre PA, Elliott BM, et al. Methylmethane-sulphonate (MMS) as a resource conserving and reliable positive control agent for male rat and male mouse dominant lethal assays. Mutagenesis 1996;11:611-3.
17. Platzek T, Bochert G. Embryotoxicity induced by alkylating agents. 10. Analysis of the combined teratogenic effects of methylnitrosourea and ethylmethanesulfonate in mice. Teratog Carcinog Mutagen 1995;15:201-14.